NOTE: THIS NEW DISCUSSION WAS SPAWNED FROM nickmd's discussion -
"David R. Moller M.D./Johns Hopkins Sarc Researcher"
Is Dr. Moller onto something??? Well, he's not the only one. Dr. Wonder Drake at Vanderbilt is looking for infectious agents related to sarcoidosis as well. The emerging research seems to support the premise of microbial involvement in the etiology of sarcoidosis. This, by the way, is the premise that the Marshmellow Poopadol is based on. He, Dr. Marshmellow, believes that there are cell wall deficient bacteria that are difficult to detect and to treat with conventional antibiotics and that THEY may be at the center of ailments classically and historically habitually labeled "autoimmune" diseases. As we all know, Marsmellow's views are highly controversial and NOT confirmed by medical science and the treatment he suggests is radical and potentially dangerous.
Here is an abstract of Dr. Drake's paper. She is conducting another survey study and needs sarcoid patients as subjects. If you are near Vanderbilt University, perhaps you can join the study.
This physi1: Emerg Infect Dis. 2002 Nov;8(11):1334-41. Links
Molecular analysis of sarcoidosis tissues for mycobacterium species DNA.
Drake WP, Pei Z, Pride DT, Collins RD, Cover TL, Blaser MJ.
Vanderbilt University School of Medicine and Veteran Affairs Medical Center, Nashville, Tennessee 37232, USA.
wonder.drake@mcmail.vanderbilt.edu
We performed polymerase chain reaction analysis, for Mycobacterium species 16S rRNA, rpoB, and IS6110 sequences, on 25 tissue specimens from patients with sarcoidosis and on 25 control tissue specimens consisting of mediastinal or cervical lymph nodes and lung biopsies. Mycobacterium species 16S rRNA sequences were amplified from 12 (48%) rpoB sequences and from 6 (24%) of the sarcoidosis specimens. In total, 16S rRNA or rpoB sequences were amplified from 15 sarcoidosis specimens (60%) but were not detected in any of the control tissues (p=0.00002, chi square). In three specimens, the sequences resembled Mycobacterium species other than M. tuberculosis. All specimens with sequences consistent with M. tuberculosis were negative for IS6110. We provide evidence that one of a variety of Mycobacterium species, especially organisms resembling M. tuberculosis, is found in most patients with sarcoidosis.
SO...the question is...what IS it going to take to prod the research world into this direction in a more fervent way?
How can we as patients effect this movement? How can our community correctly and politely inquire and perhaps help researchers in their quest for the resources to continue promising directions?
I offer these questions in order to start a discussion on how we can become involved in the process instead of just waiting and sighing for the news of a cure to come raining down from heaven.
Who's with me?
brucath



Add to the discussion